OBSAH
EDITORIAL
Zita Chovancová, Jindřich Lokaj .................................................................... 1
I. typ přecitlivělosti v patogenezi a klinické manifestaci .............................. 21
Antiinfekční imunologie................................................................................. 22
Mastocyty ve zdraví i nemoci........................................................................ 22
Umělá inteligence v alergologii a klinické imunologii ................................... 25
Mechanismy imunitní tolerance .................................................................... 27
Sympozium společnosti AstraZeneca Czech Republic s. r. o....................... 29
Sympozium společnosti Berlin-Chemie / A. Menarini
Ceska republika s. r. o.................................................................................... 29
Bronchiální astma ............................................................................................ 31
Léková hypersenzitivita................................................................................... 34
Primární a sekundární imunodeficience ......................................................... 35
Multioborová a podpůrná péče v alergologii a klinické imunologii ................ 38
Sekce laboratorní imunologie ......................................................................... 41
Zánět ve fyziologii a patologii.......................................................................... 43
I. typ přecitlivělosti v diagnostice a terapii....................................................... 47
Poruchy imunoregulace ................................................................................... 48
Eozinofily ve zdraví i nemoci............................................................................. 50
Sekce laborantů................................................................................................. 52
Sekce sester....................................................................................................... 54
Sympozium společnosti Sanofi s. r. o................................................................ 55
Sympozium společnosti S&D Pharma CZ, spol. s r. o. .................................... 56
Diferenciální diagnostika angioedémů ............................................................. 57
Choosing Wisely................................................................................................ 60
Reprodukční imunologie.................................................................................... 62
Nádorová imunologie, imunoterapie nádorů .................................................... 63
Slizniční imunita................................................................................................. 64
Sekce mladých alergologů a klinických imunologů .......................................... 66
Potravinová alergie a hypersenzitivita................................................................ 70
Transplantace a imunogenetika ........................................................................ 71
Vlivy vnějšího a vnitřního prostředí na imunitní systém .................................... 72
Nádorové mikroprostředí................................................................................... 74
POSTEROVÁ SEKCE I. ....................................................................................... 77
POSTEROVÁ SEKCE II. ...................................................................................... 88
POSTEROVÁ SEKCE III. ..................................................................................... 99
REJSTŘÍK AUTORŮ ........................................................................................... 112
PŘEDPLATNÉ ..................................................................................................... 115
POKYNY AUTORŮM .......................................................................................... 116
CONTENTS
EDITORIAL
Zita Chovancová, Jindřich Lokaj ......................................................................... 1
PROGRAMME ...................................................................................................... 9
Type-1 hypersensitivity in pathogenesis and clinical manifestation ................ 21
Anti-infectious immunity................................................................................... 22
Mast cells in health and disease....................................................................... 22
AI in allergy and clinical imunology .................................................................. 25
Immune tolerance mechanisms ....................................................................... 27
Company symposium: AstraZeneca Czech Republic s. r. o. ........................... 29
Company symposium: Berlin-Chemie / A. Menarini
Ceska republika s. r. o...................................................................................... 29
Bronchial asthma ............................................................................................ 31
Drug hypersensitivity....................................................................................... 34
Primary and secondary immunodeficiency .................................................... 35
Multidisciplinary and supportive care in allergy
and clinical imunology..................................................................................... 38
Laboratory imunology section ....................................................................... 41
Inflammation in physiology and pathology..................................................... 43
Type-1 hypersensitivity in diagnosis and therapy.......................................... 47
Immunoregulation disorders ......................................................................... 48
Eosinophils in health and disease.................................................................. 50
Laboratory technicians section ..................................................................... 52
Nurses section................................................................................................ 54
Company symposium: Sanofi s. r. o. ............................................................. 55
Company symposium: S&D Pharma CZ, spol. s r. o. .................................... 56
Diferential diagnosis of anigoedema ............................................................. 57
Choosing Wisely............................................................................................. 60
Reproductive imunology ................................................................................ 62
Tumor immunology and immunotherapy ...................................................... 63
Mucosal immunity ......................................................................................... 64
Young allergists and immunologists section ................................................ 66
Food allergy and hyperensitivity ................................................................... 70
Transplantation and immunigenetics ............................................................ 71
Influences of the external and internal milieau
on the immune system ................................................................................. 72
Tumor micromilieu ........................................................................................ 74
POSTERS I. ................................................................................................... 77
POSTERS II. ................................................................................................. 88
POSTERS III. ................................................................................................ 99
SUBSCRIPTION .......................................................................................... 115
INSTRUCTION FOR AUTHORS ................................................................... 116
